Skip to main navigation
Close
Menu
Main navigation
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action
Breadcrumb
Association for Accessible Medicines
Resources
Resources
Share
Find up-to-date information on generics and biosimilars
Filter Resources
Issues
Biosimilar User Fee Act (BsUFA)
Biosimilars
Complex Generics
Drug Approval Process (GDUFA)
Drug Prices
Drug Shortages
Generic Drug Labeling
Generic Supply Chain
IP Issues
Low Income Subsidies (LIS in Part D)
Medicaid
Medicare
NAFTA
Patent Reform
Patient Stories
Pharmaceutical Waste Take Back
Preventing Drug Abuse
Quality
REMS/Sample Acquisition Remedies
State Initiatives
Tariffs
Trade
Transparency
User Fees
Resource Type
Blog
Amicus Brief
Press Release
Infographic
Video
Report
Fact Sheet
Presentation
Press Release
Feb 7, 2019
| Rachel Schwartz
AAM: Congress Should Reject Hatch-Waxman Integrity Act of 2019
Fact Sheet
Feb 6, 2019
| Erica Klinger
Generic Medicines Save Money for Patients and Taxpayers
Blog
Feb 6, 2019
| Allen Goldberg
Alex Azar to Speak at Access! 2019
Press Release
Feb 4, 2019
| Jewel Smith
AAM Announces 2019 Board of Directors
Fact Sheet
Feb 1, 2019
| Erica Klinger
Rate-Setting Bills
Fact Sheet
Feb 1, 2019
| Erica Klinger
Drug Price Transparency Bills
Fact Sheet
Feb 1, 2019
| Erica Klinger
Generic Prescription Drug Shortage Bills
Report
Feb 1, 2019
| Erica Klinger
Medicare Part D Generic Drug Tiering Request for Comment: Implications for Patient Out-of-Pocket Spending and Part D Plan Costs
Press Release
Feb 1, 2019
| Rachel Schwartz
AAM Statement on Trump Administration’s Proposal to Lower Drug Costs by Targeting Backdoor Rebates
Blog
Jan 30, 2019
| Brett Michelin
From Sea to Shining Sea: Generic Savings State by State
Video
Jan 24, 2019
| Erica Klinger
Generics: Your Prescription for Savings
Video
Jan 17, 2019
| Erica Klinger
Rich's Story — Savings from Generic Medicines
Load More
Advocacy
Issue Overview
#Rx4StateSavings
#4GRxANTED
#MarkupMadness
State Advocacy
GDUFA/BsUFA User Fees
Biosimilars Council
Action Center
Our Impact
Join
About Us
Generic Quality
About AAM
Our Team
Our Members
Generic Medicines
Biosimilars Council
Meet Our Board
Social Commitment
Careers
Contact Us
Stories
Events
Access! 2024
GRx+Biosims 2023
Resources
All Resources
Drug Shortages White Paper
2023 Savings Report
Biosimilars Patient Resource Center
Biosimilar Research & Studies
Press Releases
Blog
Founders Blogs
Amicus Briefs
Take Action